Innovax-ND-IBD-ILT
-
EU/2/25/347/002
Intervet International B.V., Nīderlande
-
chickens; embryonated chicken eggs
Vairāk
Medicinal product information
Pharmaceutical form:
concentrate and solvent for suspension for injection
International name (active substance):
Turkey herpesvirus, strain HVT/ND/IBD/ILT, expressing fusion protein gene of NDV and VP2 protein gene of IBD virus and gD and gI glycoproteins genes of ILT virus, Live
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
04-Jul-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/347/002
1
Stikla ampula, 4000 deva
-
Credelio
450 mg
EU/2/17/206/010
Elanco GmbH, Vācija
QP53BE04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
26-Apr-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/206/010
450 mg
1
Alumīnija blisteris, 1 tablete
-
Zulvac BTV
-
EU/2/17/207/005
Zoetis Belgium S.A., Beļģija
QI04AA02
cattle; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Manufacturing Research Spain S L, Spānija
Date of authorisation/renewal:
26-Apr-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/207/005
1
Polietilēna pudele, 50 deva
-
Porcilis ColiClos
-
EU/2/12/141/009
Intervet International B.V., Nīderlande
QI09AB08
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,F4ac (K88ac) fimbrial adhesin,Echerichia coli LT toxoid,F6 fimbrial adhesin of E. coli,Toxoid Clostridium perfringens, type C
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
14-Jun-2012
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/12/141/009
250 deva
1
Stikla pudelīte, 250 deva
-
Rheumocam
0.5 mg/ml
EU/2/07/078/023
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
QM01AC06
cats
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
18-Dec-2012
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/07/078/023
15 ml
1
Flakons, 15 ml
-
Lotilaner/Milbemycin Elanco 225 mg/8,44 mg
-
EU/2/26/361/009
Elanco GmbH, Vācija
QP54AB51
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner, Milbemycin oxime
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
25-Feb-2026
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/26/361/009
1
Al/Al blisteris, 1 tablete
-
Cardalis
-
EU/2/12/142/003
Ceva Sante Animale, Francija
QC09BA07
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Spironolactone,Benazepril hydrochloride
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Ceva Sante Animale, Francija
Date of authorisation/renewal:
28-Aug-2012
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/12/142/003
5 mg/40 mg
30
Pudelīte, 1 tablete
-
Fluralaner Intervet
400 mg
EU/2/25/346/015
Intervet International B.V., Nīderlande
QP53BE02
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Fluralaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
27-Jun-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/346/015
3
Blisteris, 1 tablete
-
ERYSENG PARVO
-
EU/2/14/167/003
Laboratorios Hipra S.A., Spānija
QI09AL01
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Inactivated Erysipelothrix rhusiopathiae ,Inactivated swine parvovirus strain
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal:
05-Oct-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/167/003
1
Stikla flakons, 50 deva
-
Evalon
-
EU/2/16/194/003
Laboratorios Hipra S.A., Spānija
QI01AN01
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
suspension and solvent for oral spray
International name (active substance):
Oocysts of Eimeria necatrix, strain mednec 3+8,Oocysts of Eimeria brunetti, strain roybru 3+28,Eimeria acervulina (strain RA|3+20),Eimeria maxima (strain MCK+10),Eimeria tenella (strain Rt 3+15)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal:
12-Feb-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/16/194/003
1
Stikla pudelīte, 10000 deva
-
Porcilis PCV M Hyo ID
-
EU/2/24/319/001
Intervet International B.V., Nīderlande
QI09AL08
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Porcine circovirus type 2, ORF2 capsid protein
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
30-Aug-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/319/001
1
I tipa stikla flakons, 50 deva
-
Portela 2,5 mg
2.5 mg
EU/2/25/353/002
Zoetis Belgium S.A., Beļģija
QN02BG
cats
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Relfovetmab
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
27-Oct-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/353/002
2
Stikla flakons, 1 ml
-
Loxicom
2.5 mg
EU/2/08/090/026
Norbrook Laboratories (Ireland) Limited, Īrija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Norbrook Laboratories Limited, Lielbritānija
Date of authorisation/renewal:
12-Mar-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/090/026
2,5 mg
50
Blisteris, 10 tablete
-
RESPIVAC TRT
-
EU/2/24/314/005
Laboratorios Hipra S.A., Spānija
QI01AD01
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate for oculonasal suspension/use in drinking water
International name (active substance):
Turkey rhinotracheitis virus, strain 1062, Live
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
30-May-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/314/005
10
Stikla flakons, 1000 devas/flakonā
-
Equilis Prequenza Te
-
EU/2/05/057/002
Intervet International B.V., Nīderlande
QI05AL01
horses
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Purified haemagglutinin subunits from equine influenza viruses: A/equine-1/Praque/1/56,A/equine-2/ Newmarket /1/93,A/equine-2/Newmarket /2/93
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International Booxmer, Nīderlande
Date of authorisation/renewal:
08-Jul-2005
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
[DOC] EquilisPrequenza (08-Jul-2005)
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/05/057/002
10
Pilnšļirce, 1 deva
-
BTVPUR
-
EU/2/10/113/002
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI04AA02;QI02AA08
cattle; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Bluetongue virus serotype 8 antigen,Bluetongue virus serotype 1 antigen
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
MERIAL, Francija
Date of authorisation/renewal:
22-Dec-2015
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/113/002
10
Polipropilēna pudele, 1000 deva
-
Increxxa
100 mg/ml
EU/2/20/258/002
Elanco GmbH, Vācija
QJ01FA94
cattle; pigs; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tulathromycin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
FAREVA AMBOISE, Francija
Date of authorisation/renewal:
16-Sep-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/258/002
1
Stikla flakons, 50 ml
-
PREVEXXION RN
0.2 ml
EU/2/20/254/003
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI01AD03
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
concentrate and solvent for suspension for injection
International name (active substance):
Cell-associated live recombinant Marek’s disease (MD) virus, serotype 1,strain RN1250
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health France SCS , Francija
Date of authorisation/renewal:
20-Jul-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/254/003
4
Stikla ampula, 4000 deva
-
PRAZIVETIN
500 mg/g
EU/2/25/340/001
VETHELLAS S.A., Grieķija
QP52AA01
Gilthead
Vairāk
Medicinal product information
Pharmaceutical form:
premix for medicated feeding stuff
International name (active substance):
Praziquantel
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
23-Apr-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/340/001
8
ZBPE maiss, 2 kg
-
Clevor
30 mg/ml
EU/2/17/222/008
Orion Corporation, Somija
QN04BC04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
eye drops, solution
International name (active substance):
Ropinirole hydrochloride
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Orion Corporation, Somija
Date of authorisation/renewal:
09-Mar-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/222/008
30 mg/ml
3
ZBPE flakons, 0,6 ml
-